Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA

Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03253848	Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia	active not recruiting	N/A	202	ECOG-ACRIN Cancer Research GroupNETWORK	2	Aug 6, 2026	clinicaltrials

Data updated 23 days agoSource updated Aug 6, 2026source: clinicaltrials